Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy
Cancer Biotherapy and Radiopharmaceuticals · 2016-09 · 31 (7) · 246-252
DOI: 10.1089/cbr.2016.2034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2016-09. Verfasst von Yang Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Gynecology, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Gynecology, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China .
- 2 Department of Pathology, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China .
- 3 Department of Pharmacy, Fujian Provincial Hospital, Fujian Provincial Clinical Medical College, Fujian Medical University , Fuzhou, China .
- 4 Fujian Provincial Key Laboratory of Cardiovascular Disease, Fujian Provincial Hospital, Fujian Medical University , Fuzhou, China .
Zitieren
APA
Sun, Y., Jin, L., Liu, J. H., Sui, Y. X., Han, L. L., & Shen, X. L. (2016). Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy. Cancer Biotherapy and Radiopharmaceuticals, 31(7), 246-252. https://doi.org/10.1089/cbr.2016.2034
Vancouver
Sun Y, Jin L, Liu JH, Sui YX, Han LL, Shen XL. Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy. Cancer Biotherapy and Radiopharmaceuticals. 2016;31(7):246-252. doi:10.1089/cbr.2016.2034
BibTeX
@article{Sun2016,
author = {Sun, Yang and Jin, Long and Liu, Jia-Hua and Sui, Yu-Xia and Han, Li-Li and Shen, Xiao-Li},
title = {Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2016},
volume = {31},
number = {7},
pages = {246--252},
doi = {10.1089/cbr.2016.2034}
}
EUVIMED